BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29245991)

  • 1. The impact of metformin use on survival in prostate cancer: a systematic review and meta-analysis.
    Xiao Y; Zheng L; Mei Z; Xu C; Liu C; Chu X; Hao B
    Oncotarget; 2017 Nov; 8(59):100449-100458. PubMed ID: 29245991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of metformin therapy on incidence and prognosis in prostate cancer: A systematic review and meta-analysis.
    He K; Hu H; Ye S; Wang H; Cui R; Yi L
    Sci Rep; 2019 Feb; 9(1):2218. PubMed ID: 30778081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Metformin Use with Survival Outcomes in Urologic Cancers: A Systematic Review and Meta-Analysis.
    Yao X; Liu H; Xu H
    Biomed Res Int; 2021; 2021():5311828. PubMed ID: 34660791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis.
    Coyle C; Cafferty FH; Vale C; Langley RE
    Ann Oncol; 2016 Dec; 27(12):2184-2195. PubMed ID: 27681864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of associations between telomere length and colorectal cancer survival from observational studies.
    Wang W; Zheng L; Zhou N; Li N; Bulibu G; Xu C; Zhang Y; Tang Y
    Oncotarget; 2017 Sep; 8(37):62500-62507. PubMed ID: 28977964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Metformin Use and the Risk, Prognosis of Gynecologic Cancer.
    Yao K; Zheng H; Li T
    Front Oncol; 2022; 12():942380. PubMed ID: 35898873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Metformin on the Prognosis of Gastric Cancer Patients with Type 2 Diabetes Mellitus: A Meta-Analysis Based on Retrospective Cohort Studies.
    Li L; Huang J; Huang T; Yao J; Zhang Y; Chen M; Shentu H; Lou H
    Int J Endocrinol; 2023; 2023():5892731. PubMed ID: 36915376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of BRCA1 and BRCA2 mutations with prostate cancer risk, frequency, and mortality: A meta-analysis.
    Oh M; Alkhushaym N; Fallatah S; Althagafi A; Aljadeed R; Alsowaida Y; Jeter J; Martin JR; Babiker HM; McBride A; Abraham I
    Prostate; 2019 Jun; 79(8):880-895. PubMed ID: 30900310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of metformin use on survival in kidney cancer patients with diabetes: a meta-analysis.
    Li Y; Hu L; Xia Q; Yuan Y; Mi Y
    Int Urol Nephrol; 2017 Jun; 49(6):975-981. PubMed ID: 28271326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Metformin on Risk and Prognosis of Biliary Tract Cancer: A Systematic Review and Meta-Analysis.
    Chen J; Jin H; Zhou H; Liu K
    Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837499
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of Metformin Use on Survival and Recurrence Rate of Gastric Cancer After Gastrectomy in Diabetic Patients: A Systematic Review and Meta-analysis of Observational Studies.
    Bahardoust M; Mousavi S; Moezi ZD; Yarali M; Tayebi A; Olamaeian F; Tizmaghz A
    J Gastrointest Cancer; 2024 Mar; 55(1):65-76. PubMed ID: 37526857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival Benefit of Metformin as an Adjuvant Treatment for Head and Neck Cancer: A Systematic Review and Meta-Analysis.
    Jiao Y; Liu D; Sun Y; Chen Z; Liu S
    Front Pharmacol; 2022; 13():850750. PubMed ID: 35645803
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic value of serum alkaline phosphatase in the survival of prostate cancer: evidence from a meta-analysis.
    Li D; Lv H; Hao X; Hu B; Song Y
    Cancer Manag Res; 2018; 10():3125-3139. PubMed ID: 30214305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of metformin in cancers: An updated meta-analysis based on 80 cohort studies.
    Yang J; Yang H; Cao L; Yin Y; Shen Y; Zhu W
    Medicine (Baltimore); 2022 Dec; 101(49):e31799. PubMed ID: 36626437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of statin exposure and lung cancer survival: A meta-analysis of observational studies.
    Chen Y; Li X; Zhang R; Xia Y; Shao Z; Mei Z
    Pharmacol Res; 2019 Mar; 141():357-365. PubMed ID: 30641276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival benefits of metformin for colorectal cancer patients with diabetes: a systematic review and meta-analysis.
    Mei ZB; Zhang ZJ; Liu CY; Liu Y; Cui A; Liang ZL; Wang GH; Cui L
    PLoS One; 2014; 9(3):e91818. PubMed ID: 24647047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis.
    Meng F; Song L; Wang W
    J Diabetes Res; 2017; 2017():5063239. PubMed ID: 28271076
    [No Abstract]   [Full Text] [Related]  

  • 18. Metformin Use and Kidney Cancer Survival Outcomes: A Systematic Review and Meta-Analysis.
    Nayan M; Punjani N; Juurlink DN; Finelli A; Austin PC; Kulkarni GS; Uleryk E; Hamilton RJ
    Am J Clin Oncol; 2019 Mar; 42(3):275-284. PubMed ID: 30663998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin use and survival outcomes in endometrial cancer: a systematic review and meta-analysis.
    Xie W; Li T; Yang J; Shang M; Xiao Y; Li Q; Yang J
    Oncotarget; 2017 Sep; 8(42):73079-73086. PubMed ID: 29069850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and safety of radical prostatectomy and radiotherapy in high-risk prostate cancer: a systematic review and meta-analysis.
    Wang Z; Ni Y; Chen J; Sun G; Zhang X; Zhao J; Zhu X; Zhang H; Zhu S; Dai J; Shen P; Zeng H
    World J Surg Oncol; 2020 Feb; 18(1):42. PubMed ID: 32093688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.